Follow-The-Filings

Security

Alx Oncology Hldgs Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

6 owners 1 exit max 0.0% (Marshall Wace - Marshall ...)

owners 6
max % 0.0%
tracked value $16M
qoq A 4 R 1 E 1

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Add +0.01 pp 3,757,216 $8M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Reduce 0.00 pp 1,988,559 $4M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 1,630,940 $2M hist
Renaissance Technologies LLC 2026 Q1 0.0% Add 0.00 pp 732,599 $1M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 640,205 $723 hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Add 0.00 pp 41,095 $82 hist
Ken Griffin - Citadel Advisors LLC exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 56,732 $64 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue
Gross profit
Gross margin
Net income -$160.8M -$134.85M -$101.7M
Net margin

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $188.66M $134.35M $50.73M
Total non-current assets * $53.89M $13.42M $8.32M
Total assets $242.55M $147.78M $59.05M
Total current liabilities $36M $18.5M $24.55M
Total non-current liabilities * $16.84M $15.66M $8.51M
Total equity $189.71M $113.62M $25.98M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$130.36M -$121.91M -$84.14M
Cash from investing $44.66M $86.26M $82.59M
Cash from financing $59.29M $30.82M $362,000
Net change in cash * -$26.42M -$4.84M -$1.19M

ownership over time

filing count by report period · click a bar for that quarter’s holders